Health Care & Life Sciences » Pharmaceuticals | Adamas Pharmaceuticals Inc.

Adamas Pharmaceuticals Inc.

Adamas Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
27.19 M
Public Float
21.59 M
Adamas Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$4.61
Market Cap
$165.2 M
Shares Outstanding
27.53 M
Public Float
21.89 M

Profile

Address
1900 Powell Street
Emeryville California 94608
United States
Employees -
Website http://www.adamaspharma.com
Updated 07/08/2019
Adamas Pharmaceuticals, Inc. is a pharmaceutical company, which engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products includes ADS-5012, ADS-4101, and Namenda XR. The ADS-5102 is a treatment for levodopa-induced dyskinesia in patients with Parkinson's disease.

Financials

View All

Gregory T. Went
Chairman & Chief Executive Officer
Mardi C. Dier
Director